Old College Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Prothea is developing technology to combine lung cancer biopsy and treatment into a single hospital visit, reducing the time from diagnosis to treatment.
BiotechHealthtechMedical Devices
Co-investorsKorysMérieux Equity PartnersEarlybird Venture Capital
Rhizocore Technologies develops mycorrhizal fungal inoculum products to enhance plant growth, woodland restoration, and ecosystem resilience.
AgTechBiotechCleantechClimate TechImpact & Social GoodEdinburgh, GB
Toby Parkes(Founder)inToby Philip Parkes(Director)David Christopher Satori(Director)Jack Hooper(Chief Operating Officer)
BoardDaniel Fitzgerald(Director)
Co-investorsCollaborative FundDeep Science VenturesGrosvenor EstateScottish Enterprise
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.